The relationship between cerebral blood volume (CBV) and flow (CBF) has been widely studied. One of the most significant early studies was by Grubb et al (1974 Stroke 5 630-9), who conducted hypercapnia studies in primates with positron emission tomography (PET) and empirically found CBV = 0.8 CBF 0.38 . The exponent used here has since been known as the Grubb's exponent. In this paper, we define a similar exponent known as the modified Grubb's exponent, G , which is based on CBV and cerebral blood flow velocity (CBFV) estimated by near infrared spectroscopy (NIRS) and transcranial Doppler respectively, i.e. G = log(CBV/CBV 0 )/log(CBFV/CBFV 0 ), where CBV 0 and CBFV 0 are baseline values. The aim of this study was to estimate the nominal value of the modified Grubb's exponent in healthy human brains. We conducted hypercapnia and hypocapnia studies on 14 healthy adult subjects. The correlation coefficient between log(CBV/CBV 0 ) and log(CBFV/CBFV 0 ) is 0.71 (p < 0.0001). We found a modified Grubb's exponent of 0.13 (the 95% confidence bounds are 0.10 and 0.17) which is expectedly lower than the conventional Grubb's exponents estimated by other techniques. The modified Grubb's exponent is a simple measure to quantify the hemodynamics between local CBV and global CBFV in the brain and as such may provide insight on brain physiology. Both NIRS and transcranial Doppler techniques are noninvasive and portable, facilitating future studies in other population groups such as brain-injured patients.
Introduction
investigated the relationship between CBF and CBV in 23 primates using positron emission tomography (PET). In each primate, the arterial carbon dioxide pressure (PaCO 2 ) was lowered by hyperventilation and raised by hypoventilation so that the cerebral vascular resistance and hence CBF were changed. Using linear regression on a log scale, it was found that the relationship between CBF and CBV can be sufficiently quantified by a simple power law equation: CBV = 0.8 CBF 0.38 . The exponent here, in this case 0.38, has since been known as the Grubb's exponent.
Since then, similar studies have reported slightly different Grubb's exponents using different measurement techniques in animals and humans, ranging from 0.18 to 0.40 (Grubb et al 1974 , Lee et al 2001 , Ito et al 2003 , Mandeville et al 1999 , Jones et al 2001 , Cheung et al 2001 . Grubb's exponent has been measured mainly in two ways, namely the steady state and the dynamic state. In the steady state, the CBF and CBV have settled to steady values after a physiological challenge such as hypercapnia or hypocapnia (Grubb et al 1974 , Lee et al 2001 , Ito et al 2003 , Cheung et al 2001 . As for the dynamic state, the Grubb's exponent was often measured in neural stimulation studies in which both CBF and CBV were still changing following stimulation such as electrical stimulations (Mandeville et al 1999 , Jones et al 2001 .
At first sight, Grubb's exponent seems to lack some degree of mathematical rigor. Considering the general formulation of Grubb's exponent that CBV = A × CBF G , where A is a dimensionless constant, and G is the Grubb's exponent, it is immediately clear that the units of CBV (ml/100 g) and CBF (ml/100 g min −1 ) are different and the formulation has no obvious physical meaning. The formulation is in fact best considered as a regression equation as it was originally intended, in which a linear relationship was found between two variables. In this case, they are log(CBV) and log(CBF), and the formulation becomes log(CBV) = G × log(CBF) + log(A).
The formulation of Grubb's exponent is often expressed as a proportional change, i.e. 
(CBV/CBV
where CBV 0 and CBF 0 are the baseline values of CBV and CBF (Buxton and Frank 1997 , Mandeville et al 1999 , Friston et al 2000 , Wu et al 2002 , Boas et al 2003 , Kong et al 2004 , Zheng et al 2005 , Franceschini et al 2007 . The advantage of this expression is that the units of CBV and CBF, and the constant A have been cancelled out, and the whole equation becomes dimensionless, which circumvents the issue of unit mismatch in CBV and CBF. More importantly, equation (1) is compatible with the steady state of the windkessel model (Mandeville et al 1999) and the balloon model Frank 1997, Buxton et al 1998) which gives this proportional expression a physical meaning. Both models have been developed to explain the dynamic relationship between CBV and CBF during neural stimulation of the brain. Equation (1) is also compatible with variants of these two models (Friston et al 2000 , Kong et al 2004 , Zheng et al 2005 . According to the windkessel model, the Grubb's exponent is always smaller than 0.5 for laminar flow through a compliant and passively reacting compartment (Mandeville et al 1999) .
It is worth mentioning that the formulation of Grubb's exponent may not match the general expectation of the behaviour of CBV and CBF in certain conditions. For example, when blood ceases to flow in the brain (CBF = 0), it is expected that blood still resides in the brain (CBV = 0). In contrast, equation (1) predicts a zero CBV in such circumstances. This seemingly problematic situation can be explained by considering equation (1) in the context of the balloon model mentioned earlier. The balloon considered here has one inlet and one outlet. It is elastic and collapsed completely when there is neither inflow nor outflow of blood (CBF = 0), which means that the balloon cannot contain any blood, and therefore the blood volume is zero (CBV = 0). In reality, blood vessels will not collapse completely when there is no blood flow, and equation (1) is therefore not applicable in the absence of blood flow.
There are a number of ways to measure CBV and CBF, namely, PET (Grubb et al 1974 , Ito et al 2003 , magnetic resonance imaging (MRI) (Lee et al 2001 , Wu et al 2002 , and dynamic computed tomography (CT) (Cenic et al 1999) . While Mandeville et al (1999) employed MRI to measure CBV and laser Doppler flowmetry to measure CBF, several studies adopted an 'all optical' approach to measure both CBV and CBF using optical techniques such as NIRS (Jones et al 2001 , Cheung et al 2001 , diffuse optical tomography , laser Doppler flowmetry (Jones et al 2001) and correlation spectroscopy (Cheung et al 2001 . Although both laser Doppler flowmetry and correlation spectroscopy are based on the interaction between photons and moving red blood cells to measure blood flow, their theoretical formulations are different. Apart from cerebral hemodynamic modeling, another use of the Grubb's exponent is to act as a parameter for comparison of results. When CBV and CBF are altered, and measured in a study using a particular technique, Grubb's exponent is often calculated and compared with those obtained from other studies.
Aims
The aim of this study was to estimate a 'modified' Grubb's exponent in healthy human brains using NIRS and transcranial Doppler techniques. In comparison to other imaging techniques such as PET, MRI and dynamic CT, both NIRS and transcranial Doppler are relatively simple to use and can provide bedside monitoring in patients. However, transcranial Doppler does not measure CBF in a localized region directly. Instead, it measures the cerebral blood flow velocity (CBFV) of a major supplying blood vessel which can be considered as a global measure of the blood flow in the brain. To mark such a difference in the use of CBFV rather than CBF, we refer to this new measure as the 'modified' Grubb's exponent.
One interpretation of the Grubb's exponent in equation (1) is that it is a ratio of normalized CBV to normalized CBF in a log scale. In all previous studies, the Grubb's exponent has been shown to be smaller than 1 indicating that normalized changes in CBF are always larger than those in CBV. While the conventional Grubb's exponent quantifies the relationship between localized blood volume and localized blood flow in the brain, the newly defined modified Grubb's exponent focuses on the relationship between localized blood volume and global blood flow in the brain. Subsequently, the modified Grubb's exponent can also provide a different kind of physiological information. For example, the cerebrovascular carbon dioxide (CO 2 ) reactivity in patients, i.e. the change in CBV, CBF or CBFV in response to hypercapnia/hypocapnia, may be different globally and locally (Vernieri et al 2004) which may be assessed by CBFV and CBV, respectively. The modified Grubb's exponent can then serve as a measure of localized CBV changes per unit change of global CBFV. (Both CBV and CBFV are normalized and converted to a log scale.) In situations such as localized cerebral infarction or hemorrhage where only one part of the brain is affected, local perfusion may be altered resulting in a specific region of CBV response to hypercapnia/hypocapnia. The modified Grubb's exponent described in this paper may vary over the injured and uninjured regions of the brain, and as such may provide valuable information on the patho-physiology of the brain.
This study aims to establish a nominal value for the modified Grubb's exponent in healthy human brains. We conducted a series of experiments altering the CBV, CBF and CBFV by conducting hypocapnia and hypercapnia, and then used the NIRS and transcranial Doppler measurements to determine the modified Grubb's exponent. In the future, similar studies will be carried out in brain-injured patients so that their modified Grubb's exponents can be compared with those from healthy adults obtained here. In this paper, we also discussed the validity of using CBV to predict CBF or CBFV and vice versa, once a (modified) Grubb's exponent has been derived.
Methods

Near infrared spectroscopy
NIRS is an optical technique, which relies on the reflected light through the brain to measure CBV and oxygenation (Delpy and Cope 1997) . The NIRS monitor used in this study (NIRO-300, Hamamatsu Photonics KK) uses spatially resolved spectroscopy to measure tissue oxygen saturation and tissue haemoglobin index (THI) which is by definition a scaled measure of absolute CBV (Suzuki et al 1999) . Because of the scaling factor, THI is best used as a measure of proportional changes in CBV and as such the scaling factor can be cancelled out. The cerebral tissue oxygen saturation measurement of this NIRS monitor has previously been shown to be sensitive to intracerebral oxygenation changes in the adult head (Al-Rawi et al 2001) .
Transcranial Doppler ultrasonography
In transcranial Doppler ultrasonography, the CBFV is measured within a major artery to the brain using an non-invasive ultrasound probe positioned at the temple region of the subject (Aaslid et al 1982) , and the ultrasound beam is often focused on the middle cerebral artery. In this paper, all CBFV values refer to those measured at the middle cerebral artery. Bishop et al (1986) have shown that there is a strong correlation between percentage changes in CBF (measured by xenon CT) and CBFV (r = 0.85, p < 0.001) in response to hypercapnia. Martin et al (1990) measured CBF using radioactive microspheres and CBFV in 14 newborn lambs while altering their CBF by infusing dopamine or saline. They found a correlation between absolute values of CBF and CBFV to be r = 0.51 (p < 0.001) and provided the following prediction equation derived from regression analysis:
Despite numerous studies on the relationship between CBF and CBFV, this is the only one that provides a prediction equation.
Experiments
This study was approved by the Joint Research Ethics Committee of the National Hospital for Neurology and Neurosurgery and the Institute of Neurology. Fourteen healthy adult volunteers with median age of 31 years (range 27-39) participated in this study. A NIRS monitor (NIRO300, Hamamatsu photonics KK) was used in this study to measure THI. This NIRS monitor has 4 wavelengths (775, 826, 850 and 909 nm). Although not used in this study, changes of oxy-and deoxy-hemoglobin concentrations can also be measured by this NIRS monitor. Two optical probes were placed on the left and right sides of the forehead, respectively. The source and detector spacing for both probes was 5 cm. The probes were covered by a black cloth which shielded the probes from ambient light. The CBFV was measured by a 2 MHz transcranial Doppler flowmeter (Pioneer TC2020, Nicolet, UK) with the probe fixed in place over the right temporal region of each subject. A modified Boyles anaesthetic machine was used to deliver gas to the subject via a Mapelson E (Ayres t-piece) breathing system which was connected to a mouthpiece with the expiratory limb of 50 cm in length. The fraction of inspired oxygen (FiO 2 ) and the end tidal carbon dioxide (EtCO 2 ) were measured using an inline gas analyser (Hewlett Packard, UK) and a CO 2 SMO optical sensor (Novametrix Medical Systems Inc), respectively. The EtCO 2 reflects the amount of carbon dioxide in the brain. An increase in EtCO 2 could indicate a rise in the carbon dioxide level in the brain causing vasodilation which leads to increases in CBF, CBFV and CBV. Similarly, a decrease in EtCO 2 could indicate a drop in the carbon dioxide level in the brain causing vasoconstriction which leads to decreases in CBF, CBFV and CBV.
In the hypocapnia experiments, the subjects hyperventilated and aimed to reduce their EtCO 2 by 1.5 kPa. They maintained a stable EtCO 2 at this reduced level for 5 min and then returned to a normal breathing rate allowing EtCO 2 to return to baseline values over approximately 5 min. In the hypercapnia experiments, approximately 6% CO 2 was added to the inspired gases and was titrated to induce an increase in EtCO 2 of 1.5 kPa. The elevated EtCO 2 was maintained for 10 min and the inspired carbon dioxide fraction was then returned to zero for a further 5 min.
Data analysis
Natural fluctuations exist in both the THI and CBFV signals due to physiological oscillations such as heart beats and respiration (Elwell et al 1999 , Obrig et al 2000 , Leung et al 2008 . To minimize the effects of these fluctuations, 2 min worth of data were averaged for both THI and CBFV to obtain the baseline values (i.e. THI 0 and CBFV 0 ) for each dataset. To further minimize the effects of outliers, the averaging was performed using the trimmed mean which first removed the largest and smallest 5% of data points and then averaged the remaining data points. Alternatively, using a median filter should have a similar effect. For hypocapnia and hypercapnia, both THI and CBFV signals were settled to stable levels 3 min after the introduction of these challenges. The following 2 min worth of data were then averaged to obtain the mean THI and CBFV values, again using the trimmed mean approach. A typical example of all the recorded signals is shown in figure 1 .
As discussed earlier, THI is a measure of CBV and from now on CBV is used instead of THI in the following text. Linear regression was performed between log(CBV/CBV 0 ) and log(CBFV/CBFV 0 ), and the gradient of the regression line is the modified Grubb's exponent, G :
In an attempt to determine also the conventional Grubb's exponent, equation (2) has been used to convert CBFV into CBF. The Grubb's exponent was determined similarly with linear regression except log(CBF/CBF 0 ) was used this time instead of log(CBFV/CBFV 0 ). Table 1 shows the EtCO 2 , THI and CBFV at baseline, and during hypercapnia in each subject, and the group mean and standard deviation. The actual increase of EtCO 2 during hypercapnia was different in each subject, from 1 kPa (subjects 3 and 4) to 2.3 kPa (subject 12). Table 2 800 shows similar results for hypocapnia. The actual decrease of EtCO 2 during hypocapnia was also different in each subject, from 1.3 kPa (subjects 12) to 2.3 kPa (subject 1). In each subject, two series of THI measurements were obtained, i.e. one from the NIRS probe placed on the left side of the forehead and one from the right. It can be seen from table 1 that in certain subjects the THI on both sides of the forehead can be quite different, e.g. in subject 9, the baseline THI on the left side is 100.3 AU (arbitrary unit) while that on the right is 31.2 AU. It is worth providing more details over such a large discrepancy here. Spatially resolved spectroscopy is based on the difference of optical attenuation measured by two closely spaced detectors. In general, the higher the underlying blood volume, the larger the attenuation difference. Occasionally, a blood vessel may exist at a closer proximity to one of the detectors and causes a bias. This is likely to be the cause of such a large discrepancy of THI between both sides of the forehead observed here. However, despite the difference in the baseline values, it is expected that their proportional changes will still be similar. This is the reason why THI is often used as a relative rather than an absolute measure. This once again reiterates the fact that THI is best used as percentage changes from a baseline value, rather than an individual value for comparison. Figure 2 depicts the scatter plot of log(CBV/CBV 0 ) and log(CBFV/CBFV 0 ) for the 14 subjects. The distribution of the data points is consistent with the general understanding of CBV and CBFV during hypercapnia and hypocapnia, i.e. both CBV and CBFV tend to increase during hypercapnia because of vasodilation while they tend to decrease during hypocapnia due to vasoconstriction. It is noted that the four data points on the rightmost of figure 2 correspond to the two subjects who had the largest increases in EtCO 2 during hypercapnia, i.e. subjects 10 and 12. Table 3 shows the resulting modified Grubb's exponents and their 95% confidence bounds using CBV measurements collected from the left, the right and both sides of the forehead. The three estimates of the modified Grubb's exponent are essentially the same. The regression line in figure 2 was derived using CBV measurements from both sides of the forehead. The use of equation (2) to convert CBFV into CBF led to a Grubb's exponent of 0.30 (95% confidence bounds are 0.23 and 0.38) and a correlation coefficient of 0.74 (p <0.0001) using the converted CBF and CBV measurements from both sides of the forehead.
Results
Discussion and conclusion
Application of the modified Grubb's exponent
The physiological relationship between CBV and CBF is complex. It depends on many physiological factors such as the arteriole resistance, arterial/venous/capillary compartment volume ratio and venous compliance among others (Mandeville et al 1999) . The Grubb's exponent is one way to provide a simple quantitative measure of the haemodynamics between CBV and CBF in a population. In this paper, we introduced a similar measure for CBV and Grubb et al (1974) PET Primates, n = 23 Steady 0.38 Lee et al (2001) MRI Rats, n = 6 Steady 0.40 Jones et al (2001) Optical imaging and laser Rats, n = 10 Steady 0.31 Doppler flowmetry a Cheung et al (2001) Optical imaging and correlation Rats, n = 16 Steady 0.23 spectroscopy a Culver et al (2003) Optical imaging and correlation Rats, n = 5 Steady 0.03 b spectroscopy a Ito et al (2003) P E T H u m a n s , n = Culver et al (2003) which was conducted with ischemia in rats and hence a very different Grubb's exponent from those obtained by other studies. c In this paper, a modified Grubb's exponent of 0.13 has been found. By applying equation (2) and the same estimation technique described here, a Grubb's exponent of 0.30 has been obtained.
CBFV known as the modified Grubb's exponent. While the measurement of Grubb's exponent in humans requires imaging techniques such as PET, fMRI or dynamic CT, the measurement of the modified Grubb's exponent can be performed using simpler and bedside techniques such as transcranial Doppler and NIRS. One advantage of using NIRS is that apart from CBV, the technique can also provide oxygenation information, which although not used in this study, could provide additional insights in brain physiology. The simultaneous use of transcranial Doppler and NIRS to measure CBFV, CBV and cerebral oxygenation has been previously attempted in a study which found the measurements provide useful information about both hemodynamic and metabolic cerebral adaptive status in patients with occlusive disease in a simple, non-invasive and reliable way (Vernieri et al 2004) .
In this paper, we estimated a nominal value of 0.13 for the modified Grubb's exponent in 14 healthy adults. It is expected that this value may be different in patients with localized cerebral infarction, hemorrhage or other types of brain injuries or pathologies. Multichannel NIRS systems (optical topography) are now available commercially which can measure regional CBV and oxygenation changes (Koizumi et al 2003) . With a multichannel NIRS system, it can be envisaged that experiments can be performed to estimate the regional modified Grubb's exponents over different parts of the head of a brain-injured patient which could provide useful information about the hemodynamics of an injured brain. The resulting modified Grubb's exponent can also be used in the mathematical modeling of cerebral haemodynamics in these pathological conditions.
Comparison between the conventional and modified Grubb's exponents
It is generally believed that changes in CBF will follow those in CBFV as long as the crosssectional area of the vessel targeted by the transcranial Doppler remains constant during the measurement, and various studies showed that this is indeed the case in healthy subjects during hypercapnia (Panerai 1998) . CBF and CBFV however have different baseline values. Therefore, although their changes might be correlated during hypercapnia, the actual values of percentage changes are different. This is the reason why the typical value of the modified Grubb's exponent is expected to be different from that of the conventional Grubb's exponent. Table 4 lists a number of previous studies on the measurements of CBV and CBF using various measuring techniques and the Grubb's exponents found. In comparison, the modified Grubb's exponent found here was smaller in value. This is in fact expected because previous studies have shown that the percentage change in CBFV is larger than that in CBF during hypercapnia measured using transcranial Doppler and Xenon CT (Bishop et al 1986 , Ulrich et al 1995 . In other words, a larger value of CBFV (versus CBF) is expected in the denominator of the modified Grubb's exponent as shown in equation (3), resulting in a smaller modified Grubb's exponent (versus the conventional Grubb's exponent). In the case of patients, it has been pointed out that CBFV and CBF may vary differently with intracranial pathology (Brauer et al 1998 , Pindzola et al 2001 , and therefore the modified Grubb's exponent can offer a different perspective on cerebral hemodynamics compared to the conventional Grubb's exponent.
Most of the studies shown in table 4 were carried out in animals except one study (Ito et al 2003) which found a Grubb's exponent of 0.29 in nine human subjects. Equation (2) has been derived from an animal study, and strictly speaking, it is not appropriate to use it in the human study here. Despite this concern, it is interesting to see that if we apply this equation to convert CBFV into CBF, we would theoretically be able to derive a (conventional) Grubb's exponent. Using this approach and the same data, a Grubb's exponent of 0.30 (included in table 4) has been obtained which is similar in value to those found by other studies, especially the Ito study (Ito et al 2003) , and could provide evidence that equation (2) may also be valid in humans. Also, the 95% confidence bounds of this Grubb's exponent (0.23 and 0.38) are within the range of those previously reported as shown in table 4.
Predicting CBV with CBFV measurement
One may wonder whether it is appropriate to use equation (3) as a predictive equation to predict CBV from CBFV using the modified Grubb's exponent (0.13) found in this study. The scattering of the data points on figure 2 is large but not atypical of this kind of study. As shown in figure 2, a wide prediction interval (outer dotted lines) exists for the regression line indicating that the prediction of relative CBV using a single measurement of relative CBFV will result in a large uncertainty. In other words, it is not appropriate to use the modified Grubb's exponent formulation to predict CBV based on a CBFV measurement on an individual basis. The confidence interval (inner dotted lines) of the regression line is narrower showing that predicting relative CBV using the mean of relative CBFV in a population would provide a higher certainty.
Predicting CBF/CBFV with CBV measurement
In some studies, the Grubb's exponent was inverted and used to predict relative CBF based on relative CBV, i.e. 
where β = 1/G (Franceschini et al 2007) . For NIRS, this approach has a particular advantage because CBV is often easier to measure than CBF. In particular, if CBF can be predicted from CBV measurements, the cerebral metabolic rate of oxygen can also be derived. Although equation (4) seems algebraically consistent with equation (1), there is a subtle problem to use equation (4) for prediction. In the original regression analysis based on equation (1), the independent variable is log(CBF/CBF 0 ) and the dependent variable is log(CBV/CBV 0 ). In other words, the Grubb's exponent found is only supposed to be valid for predicting CBV/CBV 0 based on CBF/CBF 0 but not vice versa. (It is noted that both CBF and CBV changes are a consequence of CO 2 changes and in this sense both CBV and CBF are dependent variables. However, for the sake of linear regression, one variable is always defined as the independent variable, i.e. in this case CBF, while the other one as dependent variable, i.e. CBV.) All the studies listed in table 4 were based on equation (1) in the estimation of the Grubb's exponents, G. If they were to use instead log(CBV/CBV 0 ) as the independent variable and log(CBF/CBF 0 ) the dependent variable in the regression analysis, i.e. equation (4), they would have obtained a β which would not be equal to 1/G. This is because the variances in log(CBF/CBF 0 ) and log(CBV/CBV 0 ) measurements would have been different. In summary, it is not strictly appropriate to use any values of the Grubb's exponent listed in table 4 to predict CBF based on CBV measurements. The more conventional use of the Grubb's exponent in the current literature is in the mathematical modeling of the cerebral haemodynamics (Mandeville et al 1999 , Buxton and Frank 1997 , Buxton et al 1998 , Friston et al 2000 , Kong et al 2004 , Zheng et al 2005 . Similarly, it is also not appropriate to use the modified Grubb's exponent estimated here (G = 0.13) to predict CBFV based on CBV measurement. As an example, linear regression with log(CBV/CBV 0 ) as the independent variable and log(CBFV/CBFV 0 ) as the dependent variable will result in a β = 3.9 which is different from 1/G (= 1/0.13 = 7.7).
